Japan to Allow Limited Human Embryonic Cloning
By Nature,
Nature
| 05. 28. 2008
Last week, an expert committee in Japan's science ministry agreed to lift a 2001 ban on human cloning for research purposes. The amendment, expected to be effective later this year, maps out rigorous ethical regulations under which the research could proceed. Reproductive cloning would still be illegal.
A group in Japan has expressed intentions to clone embryos for research. But serious hurdles remain, including the low availability of human eggs for research due to strict prohibitions on compensation.
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...
By Nahlah Ayed, CBC Listen | 10.22.2025
Egg freezing is one of today’s fastest-growing reproductive technologies. It's seen as a kind of 'fertility insurance' for the future, but that doesn’t address today’s deeper feelings of uncertainty around parenthood, heterosexual relationships, and the reproductive path forward. In this...